These results illustrate that FDX1 expression was correlated with the tumour-immune microenvironment, and the combination of FDX1-correlated tumour-infiltrating immune cells helped stratify risk and predict prognosis in ccRCC. The gene discussed is FDX1; the disease is nonpapillary renal cell carcinoma.